openPR Logo
Press release

Pulmonary Drug Delivery Systems Market Shows Impressive Growth with Recent Demand by Top Countries with AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline plc, Novartis AG and More

02-06-2019 05:03 AM CET | Health & Medicine

Press release from: Allied Market Research

Pulmonary Drug Delivery Systems Market

Pulmonary Drug Delivery Systems Market

Pulmonary drug delivery systems deliver drug to the lung for the treatment of diseases of the respiratory tract. This route is preferred broadly due to non-invasive technique, large surface area for absorption, high blood circulation, and permeability rate.

Key players in the market include AstraZeneca plc., Boehringer Ingelheim Gmbh, GlaxoSmithKline plc, Novartis AG, Koninklijke Philips N.V., 3M company, Actelion Pharmaceuticals Ltd, Clement Clarke International, Briggs Healthcare, and Aerogen.

Get Sample PDF Brochure of Pulmonary Drug Delivery Systems Market Study at : https://www.alliedmarketresearch.com/request-toc-and-sample/2944

Rise in prevalence of chronic diseases such as tuberculosis, bronchitis and chronic obstructive pulmonary disease, limitations of traditional treatments for pulmonary delivery, better penetrability of drug, minimum dosage requirement, technological advancements, and increase in smoking is expected to drive the market growth. However, regulatory issues related to approval of pulmonary drug delivery systems and high pricing pressures majorly limit the market growth. Factors such as growth opportunities in emerging nations and rise of online marketing channels offer growth opportunities for the market during the forecast period.

The global pulmonary drug delivery systems market is categorized on the basis of product, application, distribution channel, and geography. On the basis of product, it is divided into metered dose inhalers (manually-actuated pressurized inhaler and breath-actuated pressurized inhaler), nebulizers (jet nebulizers, ultrasonic nebulizers, and vibrating mesh nebulizers), and dry powder inhalers (single dose inhalers and multi-dose inhalers). . On the basis of application, the market is segregated into asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD), and others.

On the basis of distribution channel, it is further classified into retail pharmacies, hospital pharmacies, and e-commerce. By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Key Benefits

• The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2016 to 2023 which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis by product helps in understanding the various types of products used for pulmonary drug delivery.
• Comprehensive analysis of all geographical regions is provided, which helps determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly, which elucidates the competitive outlook of the global market.

Do Purchase Enquiry at : https://www.alliedmarketresearch.com/purchase-enquiry/2944

About us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary Drug Delivery Systems Market Shows Impressive Growth with Recent Demand by Top Countries with AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline plc, Novartis AG and More here

News-ID: 1562928 • Views: 382

More Releases from Allied Market Research

Chemical Intermediates Market : Latest Market Trends & Forecast are being Done a …
Allied Market Research published a new report, titled, Chemical Intermediates Market: Global Opportunity Analysis and Industry Forecast, 2020–2027. The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to
Infant Sling Market 2020 Detailed Analysis, Size Estimates, Share, Trends, Key P …
Infant sling is a baby care product, designed to hold and carry the baby on one’s chest or back. Infant slings are made from soft fabric that holds the baby. This product is designed for durability, safety, and comfort level of infants. Infant Slings are also known as Baby-Wearing. They provide mobility and convenience especially when pushing a stroller is not a choice. Also, it enables the care giver to
Cable Conduit Systems Market: Growing Demand for Safer and Secure Wiring Systems …
Allied Market Research published a new report, titled, “Cable Conduit Systems Market by Type (Rigid Cable Conduit System, Metallic, Non-Metallic, Flexible Cable Conduit System, Metallic, Non-Metallic), End Use (Manufacturing, Commercial construction, Residential construction, Intelligent transportation systems) - Global Opportunity Analysis and Industry Forecast, 2019-2026.” The research report offers an in-depth analysis of the current market scenario, estimates, revolving aspects, and dynamic forces of the industry from 2019 to 2026 to identify
Smart Exoskeleton Market Applications, Trends, and Investment Opportunities | Ma …
Allied Market Research published a new report, titled, “Smart Exoskeleton Market by Component (Sensors, Actuators, Power Source, Control System, and Others), Type (Soft Exoskeleton and Rigid Exoskeleton), Body Part (Upper Body, Lower Body, and Full Body) and Application (Industrial, Healthcare, Military, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026.” The research report offers an in-depth analysis of the current market scenario, estimates, revolving aspects, and dynamic forces of the industry

All 5 Releases


More Releases for Pulmonary

Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
Global Pulmonary Arterial Hypertension Market to 2024
Global Pulmonary Arterial Hypertension (PAH) market was valued at $5.0bn in 2015 and is forecast to grow at a modest 6.0% CAGR between 2015 and 2024, to result in 2024 global sales of $9.0bn. PAH is broadly split into two classes, primary or secondary. Primary pulmonary hypertension (PPH) refers to pulmonary hypertension occurring without an identifiable cause. Secondary pulmonary arterial hypertension (PAH) occurs in association with some other identifiable medical condition.
Pulmonary Fibrosis Market Professional Survey Report 2017
Global Pulmonary Fibrosis Market: Snapshot Pulmonary fibrosis belongs to the family of interstitial diseases that can lead to damage of the lungs. As the lung tissue becomes stiff and thickened, it interferes with a person’s ability to breathe. The scarring of lung tissues is associated with a multitude of factors. However, in most cases, the cause of the problem can’t be determined. This state is termed as idiopathic pulmonary fibrosis. While the
Pulmonary Drugs 2024 Market Research Report
Global Pulmonary Drugs Market: Snapshot The global pulmonary drugs market has been the key area of focus and the most crucial market for the healthcare industry in the last couple of years. However, the market is expected to witness a significant decline over the forecast period with a -6.3% CAGR from 2016 to 2024. The market is anticipated to fall to US$28,082.1 mn from a valuation of US$48,039.7 mn in
Latest Report: Global Pulmonary Hypertension Market
MarketResearchReports.Biz presents this most up-to-date research on "Pulmonary Hypertension-Pipeline Insights, 2017" DelveInsights, Pulmonary Hypertension-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Pulmonary Hypertension. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations,